Fox Chase Cancer Center and Fox Chase – Temple Urologic Institute Physician Joshua Cohn to Serve as Consultant to Shriners Children’s Philadelphia

Dr. Cohn
Joshua Cohn, MD, FPMRS, will serve as a consultant at Shriners Children’s Philadelphia.

PHILADELPHIA (February 13, 2024) — As part of a recently announced collaboration, Joshua Cohn, MD, FPMRS, an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, will serve as a consultant at Shriners Children’s Philadelphia. He will care for patients with neurogenic urologic conditions, in which a patient lacks bladder control due to injury, neurological disorders, or congenital malformations.

“I am very excited and grateful for this collaboration, which we believe represents a significant step forward for the Urologic Institute, but far more importantly, for patient care. We aim to provide important services to both our local community here in Philadelphia and the national and international clientele of Shriners Children’s Philadelphia,” Cohn said.

In addition to his exceptional qualifications and reputation as a leading expert in the field of neurourology, Cohn is also known for his specialization in female pelvic medicine and reconstruction. He offers unique expertise in pelvic organ prolapse, neuromodulation, urinary incontinence, bladder augmentation and urinary diversion, complex bladder pathology, and vaginal reconstruction.

Shriners Children’s Philadelphia provides specialty care to the Philadelphia community and beyond. For over 95 years, it has cared for children with routine and rare orthopedic conditions, including fractures, sports injuries, scoliosis, and spinal cord injuries.

“We are genuinely appreciative and enthusiastic about having the Fox Chase -Temple Urologic Institute and Dr. Cohn join our care team at Shriners Children’s Philadelphia,” said Gregory Passanante, DNP, MBA, RN, CNOR, Northeast Market Administrator for Shriners. “Their addition is a significant step forward in more comprehensive care for our patients, providing vital services to children with urologic care needs related to musculoskeletal conditions. The impact will be immediate and felt within the entire Shriners Children’s community.”

Cohn has established himself as a regional and national authority in the field of urology, particularly in the specialized areas of neurourology and female pelvic medicine and reconstructive surgery. Since 2017, his expertise and leadership have been instrumental in shaping advanced urologic care and education. He has contributed significantly to the field through his roles in medical education and fellowship directorship, focusing on genitourinary reconstructive surgery.

His dedication to advancing urological practices and his commitment to mentorship have positioned him as a key figure in the medical community, influencing both the current and next generation of urologists. His work encompasses a broad spectrum of complex urological conditions, driving forward both clinical and surgical innovations in patient care.

Cohn received his medical degree from the University of Michigan Medical School. He went on to complete an internship in general surgery and residency in urology at the University of Chicago Medical Center and a fellowship in female pelvic medicine and reconstructive surgery and neurourology at Vanderbilt University Medical Center.

Cohn is a member of the American Urological Association; the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction; the International Continence Society; and the Society of Genitourinary Reconstructive Surgeons.

All care and services at Shriners Children’s Philadelphia are provided regardless of the families’ ability to pay or insurance status. Shriners Children’s Philadelphia is part of the Shriners Children’s healthcare system.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427